Related references
Note: Only part of the references are listed.The p38 MAPK-regulated PKD1/CREB/Bcl-2 pathway contributes to selenite-induced colorectal cancer cell apoptosis in vitro and in vivo
Kaiyan Hui et al.
CANCER LETTERS (2014)
Overcoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins
Carolien Boeckx et al.
CANCER LETTERS (2014)
Genomic analysis of drug resistant gastric cancer cell lines by combining mRNA and microRNA expression profiling
Zhangqian Chen et al.
CANCER LETTERS (2014)
Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43
J. L. Munoz et al.
CELL DEATH & DISEASE (2014)
Oncogenic B-RafV600E abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells
Ling Zhang et al.
CANCER LETTERS (2013)
Reversing the Warburg Effect as a Treatment for Glioblastoma
Ethan Poteet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Up-regulation of USP2a and FASN in gliomas correlates strongly with glioma grade
Bang-Bao Tao et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Gliomatosis cerebri: clinical characteristics, management, and outcomes
Selby Chen et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors
Katherine L. Jameson et al.
NATURE MEDICINE (2013)
Early Chk1 Phosphorylation Is Driven by Temozolomide-Induced, DNA Double Strand Break- and Mismatch Repair-Independent DNA Damage
Motokazu Ito et al.
PLOS ONE (2013)
Oleanolic Acid Suppresses Migration and Invasion of Malignant Glioma Cells by Inactivating MAPK/ERK Signaling Pathway
Guocai Guo et al.
PLOS ONE (2013)
MEK1/2 dual-specificity protein kinases: Structure and regulation
Robert Roskoski
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Chemoresistance to Temozolomide in Human Glioma Cell Line U251 is Associated with Increased Activity of O 6-methylguanine-DNA Methyltransferase and Can be Overcome by Metronomic Temozolomide Regimen
Qiang Pan et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis
Luigina Graziosi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients
Sameer Agnihotri et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The Synergistic Therapeutic Effect of Temozolomide and Hyperbaric Oxygen on Glioma U251 Cell Lines is Accompanied by Alterations in Vascular Endothelial Growth Factor and Multidrug Resistance-associated Protein-1 Levels
X-Y Lu et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
Jeffrey R. Infante et al.
LANCET ONCOLOGY (2012)
Nix Protein Positively Regulates NF-κB Activation in Gliomas
Yuntao Lu et al.
PLOS ONE (2012)
Neuronal Transcription Factors Induce Conversion of Human Glioma Cells to Neurons and Inhibit Tumorigenesis
Junli Zhao et al.
PLOS ONE (2012)
Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice
Dinorah Friedmann-Morvinski et al.
SCIENCE (2012)
Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine
ZhenYu Zhao et al.
BRAIN RESEARCH BULLETIN (2011)
Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma
Huiling Shen et al.
EXPERIMENTAL HEMATOLOGY (2011)
Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy
Xing Gong et al.
NEUROLOGY (2011)
MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis
Atsushi Sato et al.
STEM CELLS (2011)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Essential Role of TRPC6 Channels in G2/M Phase Transition and Development of Human Glioma
Xia Ding et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells
Xianling Guo et al.
BMC CANCER (2008)
MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments
Ellen Skarpen et al.
FASEB JOURNAL (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
A Critical Role for FBXW8 and MAPK in Cyclin D1 Degradation and Cancer Cell Proliferation
Hiroshi Okabe et al.
PLOS ONE (2006)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mutation analysis of B-RAF gene in human gliomas
D Basto et al.
ACTA NEUROPATHOLOGICA (2005)
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
TJ MacDonald et al.
NATURE GENETICS (2001)
SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance
M Barancík et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)